HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Anixa Biosciences (NASDAQ:ANIX) and maintained a price target of $12.
December 07, 2023 | 11:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reaffirmed a Buy rating on Anixa Biosciences with a $12 price target.
The reiteration of a Buy rating and the maintenance of a $12 price target by a reputable analyst could lead to increased investor confidence and a potential short-term positive impact on ANIX's stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100